Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 307350, 9 pages
http://dx.doi.org/10.1155/2015/307350
Research Article

Therapeutic Effects of TianDiJingWan on the Aβ25–35-Induced Alzheimer’s Disease Model Rats

1Department of Encephalopathy, Wuhan Hospital of Traditional Chinese Medicine, Wuhan 430030, China
2Department of Pharmacy, Tongji Hospital Affiliated with Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

Received 25 September 2014; Revised 3 February 2015; Accepted 4 February 2015

Academic Editor: Mani Vasudevan

Copyright © 2015 Zhijie Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Ballard, S. Gauthier, A. Corbett, C. Brayne, D. Aarsland, and E. Jones, “Alzheimer's disease,” The Lancet, vol. 377, no. 9770, pp. 1019–1031, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Heinrich and H. L. Teoh, “Galanthamine from snowdrop—the development of a modern drug against Alzheimer's disease from local Caucasian knowledge,” Journal of Ethnopharmacology, vol. 92, no. 2-3, pp. 147–162, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. V. S. Sierpina, M. Sierpina, J. A. Loera, and L. Grumbles, “Complementary and integrative approaches to dementia,” Southern Medical Journal, vol. 98, no. 6, pp. 636–645, 2005. View at Google Scholar · View at Scopus
  4. B. Benjamin and A. Burns, “Donepezil for Alzheimer's disease,” Expert Review of Neurotherapeutics, vol. 7, no. 10, pp. 1243–1249, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. L. Onor, M. Trevisiol, and E. Aguglia, “Rivastigmine in the treatment of Alzheimer's disease: an update,” Clinical Interventions in Aging, vol. 2, no. 1, pp. 17–32, 2007. View at Google Scholar · View at Scopus
  6. M. Villarroya, A. G. García, J. Marco-Contelles, and M. G. López, “An update on the pharmacology of galantamine,” Expert Opinion on Investigational Drugs, vol. 16, no. 12, pp. 1987–1998, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. W. L. Klein, G. A. Krafft, and C. E. Finch, “Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?” Trends in Neurosciences, vol. 24, no. 4, pp. 219–224, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. D. J. Selkoe, “Alzheimer's disease is a synaptic failure,” Science, vol. 298, no. 5594, pp. 789–791, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Hefti, W. F. Goure, J. Jerecic, K. S. Iverson, P. A. Walicke, and G. A. Krafft, “The case for soluble Aβ oligomers as a drug target in Alzheimer's disease,” Trends in Pharmacological Sciences, vol. 34, no. 5, pp. 261–266, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Su, Q. Wang, C. Wang, K. Chan, Y. Sun, and H. Kuang, “The treatment of Alzheimer's disease using Chinese Medicinal Plants: from disease models to potential clinical applications,” Journal of Ethnopharmacology, vol. 152, no. 3, pp. 403–423, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. H. T. Jin and Z. J. Li, “Clinical observation of TianDiJing Pill for the treatment of phlegm obstructing intelligence type vascular dementia,” Hubei Journal of Traditional Chinese Medicine, vol. 31, no. 3, pp. 13–14, 2009 (Chinese). View at Google Scholar
  12. H. T. Jin and W. Zhang, “Acupuncture method combined with Tiandijing pill in the treatment of vascular dementia,” Hubei Journal of Traditional Chinese Medicine, vol. 35, no. 1, pp. 9–10, 2012 (Chinese). View at Google Scholar
  13. Z. J. Li and H. B. Mei, “Clinical research of TianDiJing Pill for the treatment of mild cognitive impairment,” Hubei Journal of Traditional Chinese Medine, vol. 29, no. 10, pp. 10–12, 2007. View at Google Scholar
  14. X. Liu and M. Y. Wang, “Improving effects of gastrodin on learning and memory in model rats with Alzheimer disease induced by intra-hippocampal Aβ140 injection,” Chinese Journal of Clinical Pharmacology and Therapeutics, vol. 17, no. 4, pp. 408–411, 2012 (Chinese). View at Google Scholar
  15. Z. Wen, Y. S. Xiao, N. Tang et al., “Effect and cytotoxicity of polygonatum sibiricum polysaccharides against hypoxic necrosis and apoptosis of neurons,” Pharmacology and Clinics of Chinese Materia Medica, vol. 22, no. 2, pp. 29–31, 2006 (Chinese). View at Google Scholar
  16. Z. Xue, Y. Guo, S. Zhang et al., “Beta-asarone attenuates amyloid beta-induced autophagy via Akt/mTOR pathway in PC12 cells,” European Journal of Pharmacology, vol. 741, pp. 195–204, 2014. View at Publisher · View at Google Scholar
  17. R. G. M. Morris, P. Garrud, J. N. P. Rawlins, and J. O'Keefe, “Place navigation impaired in rats with hippocampal lesions,” Nature, vol. 297, no. 5868, pp. 681–683, 1982. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Figueiró, J. Ilha, V. M. Linck et al., “The Amazonian herbal Marapuama attenuates cognitive impairment and neuroglial degeneration in a mouse Alzheimer model,” Phytomedicine, vol. 18, no. 4, pp. 327–333, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Maurice, M. Hiramatsu, J. Itoh, T. Kameyama, T. Hasegawa, and T. Nabeshima, “Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia,” Brain Research, vol. 647, no. 1, pp. 44–56, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. C. A. Netto and I. Izquierdo, “On how passive is inhibitory avoidance,” Behavioral and Neural Biology, vol. 43, no. 3, pp. 327–330, 1985. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Liu, Q. Hua, H. Lei, and P. Li, “Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains,” Journal of Ethnopharmacology, vol. 137, no. 2, pp. 1035–1046, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Jeon, S. Bose, J. Hur et al., “A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 783–789, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-C. Miao, J.-Z. Tian, J. Shi, and M. Mao, “Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial,” Zhong Guo Zhong Xi Yi Jie He Za Zhi, vol. 10, no. 4, pp. 390–397, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. B. J. Ding, W. W. Ma, L. L. He et al., “Soybean isoflavone alleviates β-amyloid 1-42 induced inflammatory response to improve learning and memory ability by down regulation of Toll-like receptor 4 expression and nuclear factor-κB activity in rats,” International Journal of Developmental Neuroscience, vol. 29, no. 5, pp. 537–542, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. E. Hoey, F. Buonocore, C. J. Cox, V. J. Hammond, M. S. Perkinton, and R. J. Williams, “AMPA receptor activation promotes non-amyloidogenic amyloid precursor protein processing and suppresses neuronal amyloid-β production,” PLoS ONE, vol. 8, no. 10, Article ID e78155, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Majláth, J. Toldi, and L. Vécsei, “The potential role of kynurenines in Alzheimer’s disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors,” Journal of Neural Transmission, vol. 121, no. 8, pp. 881–889, 2014. View at Publisher · View at Google Scholar
  27. Z.-C. Wang, J. Zhao, and S. Li, “Dysregulation of synaptic and extrasynaptic N-methyl-D-aspartate receptors induced by amyloid-β,” Neuroscience Bulletin, vol. 29, no. 6, pp. 752–760, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. R. S. Jones and A. D. Waldman, “1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia,” Neurological Research, vol. 26, no. 5, pp. 488–495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Emilien, J.-M. Maloteaux, K. Beyreuther, and C. L. Masters, “Alzheimer disease: mouse models pave the way for therapeutic opportunities,” Archives of Neurology, vol. 57, no. 2, pp. 176–181, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. F. G. Gervais, D. Xu, G. S. Robertson et al., “Involvement of caspases in proteolyticcleavage of Alzheimer’s amyloid-beta precursor protein and amyloidogenic A beta peptide formation,” Cell, vol. 97, no. 3, pp. 395–406, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. T. E. Golde, D. Dickson, and M. Hutton, “Filling the gaps in the Aβ cascade hypothesis of Alzheimer's disease,” Current Alzheimer Research, vol. 3, no. 5, pp. 421–430, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. S. S. Shaftel, W. S. T. Griffin, and M. K. O’Banion, “The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective,” Journal of Neuroinflammation, vol. 5, article 7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. B. B. A. McNaull, S. Todd, B. McGuinness, and A. P. Passmore, “Inflammation and anti-inflammatory strategies for Alzheimer's disease—a mini-review,” Gerontology, vol. 56, no. 1, pp. 3–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. R. T. Perry, J. S. Collins, H. Wiener, R. Acton, and R. C. P. Go, “The role of TNF and its receptors in Alzheimer's disease,” Neurobiology of Aging, vol. 22, no. 6, pp. 873–883, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Y. Zou and F. T. Crews, “TNFα potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF-κB inhibition,” Brain Research, vol. 1034, no. 1-2, pp. 11–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. E. L. Tobinick and H. Gross, “Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration,” Journal of Neuroinflammation, vol. 5, article 2, 2008. View at Publisher · View at Google Scholar · View at Scopus